The data showed that roughly 65% of the cells in the oxygenated devices remained viable compared to roughly 20% in control devices.

GEN Live panelists will explore how stem cells are transforming disease modeling, drug discovery, and personalized medicine with perspectives on clinical trial progress and hurdles such as ...

Study findings indicate that environmentally relevant doses of OLA bioplastics may be “more toxic” to the placenta than ...

Whether Judge Murphy’s ruling holds through appeal will determine how much institutional credibility can be recovered.

Researchers suggest modulating intestinal microbiota or antigen-presenting activity of IECs represents new approaches to treating autoimmune neurological disease.

Beyond resistance‑associated genes, the researchers uncovered deep geographic population structure and high overall genetic diversity.

UCB has achieved 15 FDA approvals or indication expansions, nine of which were secured in the past three years.

The data shows that inhibiting TIE2 with rebastinib could prevent new abnormalities from forming in the brain with fewer side effects.

A new approach engineers immune cells to recognize byproducts of cancer cells to trigger migration toward the tumor.

It is well known that chronic inflammation can increase a person’s cancer risk, but the underlying mechanisms remain unknown. Now, a new study reveals, in a mouse model of colitis, gut tissues may ...

Many organizations still lack structured media optimization and alignment between development and manufacturing, according to Lonza.